SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-061772
Filing Date
2021-12-30
Accepted
2021-12-30 17:10:03
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 sprb-s3.htm S-3 561286
2 EX-4.3 sprb-ex43_89.htm EX-4.3 475786
3 EX-4.6 sprb-ex46_87.htm EX-4.6 146199
4 EX-4.7 sprb-ex47_88.htm EX-4.7 165501
5 EX-4.8 sprb-ex48_86.htm EX-4.8 118498
6 EX-5.1 sprb-ex51_107.htm EX-5.1 51710
7 EX-23.1 sprb-ex231_128.htm EX-23.1 5277
8 GRAPHIC gcym0cgubikj000001.jpg GRAPHIC 33824
9 GRAPHIC gas0ectcvxjy000001.jpg GRAPHIC 9680
  Complete submission text file 0001564590-21-061772.txt   1585456
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-261960 | Film No.: 211533622
SIC: 2834 Pharmaceutical Preparations